9th Annual Biomarkers Congress

Epidemiology: Harvard University

Total Score People Score Events Score
84 77 16
Date Event Presentation Speakers
July 21, 2013 54th Annual Short Course on Medical and Experimental Mammalian Genetics C hromosome Struc ture and Function Jeanne Lawrence
Saturday, July 27 Pecking at the Origin of Natural Variation: Insights from Darwin’s Finches and Other Birds Arkhat Abzhanov
Friday, August 2 Reawakening Fetal Hemogl o bin for Therapy: An Old Problem with New Prospects Stuart Orkin
May 31, 2013 ASCO Annual Meeting 2013 Optimizing the Role of Advanced Practice Professionals in Oncology Practice Lawrence N. Shulman
Hot Pathways for Targeted Therapy of B-Cell Malignancies James E. Bradner
Beyond Trastuzumab and Lapatinib: New Options for HER2-Positive Breast Cancer Ian E. Krop
Clinical Management, Molecular Alterations, and Future Perspectives in Urothelial Cancer David Kwiatkowski
Cancer Stem Cells: A New and Better Target in Pediatric Oncology? Scott A. Armstrong, George Daley
Reaping the Rewards of the Cancer Genome Atlas Project Levi A Garraway
Improving Cancer Care through Health Information Technology: Ethics and Practicality Lawrence N. Shulman
Education Sessions Robert G Maki, Stephen T Sonis
Education Sessions Deborah Schrag
Education Sessions Tracy T Batchelor
Education Sessions Michael B. Atkins, Jennifer A. Ligibel
Educations Sessions Monica M. Bertagnolli
Education Sessions Bruce E. Johnson, Elizabeth R. Gerstner
April 6, 2013 AACR Annual Meetings EPIGENETIC TARGETS FOR CANCER Anjana Rao, James E. Bradner
Developmental Origins of Cancer Chairperson: Richard J. Gilbertson, St. Jude Children's Research Hospital, Memphis, TN Stuart H. Orkin
Blood-Based Molecular Analysis of Cancer Daniel A Haber
Intrinsic and Microenvironment-Dependent Adaptive Responses that Regulate Drug Resistance Chairperson: Joan S. Brugge, Harvard Medical School, Boston, MA Joan S Brugge
The Interface Between Development and Cancer Using Model Organisms Chairperson: Michael M. Shen, Columbia University, New York, NY Leonard I. Zon
Emerging Single Cell Technologies in Cancer Research Chairperson: Garry P. Nolan, Stanford University School of Medicine, Stanford, CA Claude Lechene
Mutations in Epigenetic Regulators in Cancer Chairperson: Scott A. Armstrong, Memorial Sloan-Kettering Cancer Center, New York, NY Scott A. Armstrong
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Timothy J Mitchison
Translational Control and Stress Response Pathways in Cancer Chairperson: Davide Ruggero, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA Karen Cichowski
Developmental and Molecular Origins of Brain Tumors Co-Chairpersons: Suzanne J. Baker, St. Jude Children's Research Hospital, Memphis, TN, and Cameron W. Brennan, Memorial Sloan-Kettering Cancer Center, New York, NY Cameron W Brennan
Synthetic Lethality and Genetic Approaches to Cancer Chairperson: Stephen J. Elledge, Harvard Medical School, Boston, MA Stephen J Elledge
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA Raju Kucherlapati
The Stanley J. Korsmeyer Memorial Symposium: Targeting Cell Death Pathways for Cancer Therapy Chairperson: Anthony G. Letai, Dana-Farber Cancer Institute, Boston, MA Anthony G. Letai
The Origins and Clinical Implications of Precancerous Lesions Chairperson: Cory Abate-Shen, Columbia University Irving Comprehensive Cancer Center, New York, NY Kornelia Polyak
Noncoding RNAs and Cancer Chairperson: Phillip A. Sharp, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA Jeannie T. Lee
New Cancer Vaccines Chairperson: Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA Glenn Dranoff
The Origins and Neoplastic Progression of Barrett's Esophagus Co-Chairpersons: Timothy C. Wang, Columbia University Medical Center, New York, NY, and Brian J. Reid, Fred Hutchinson Cancer Research Center, Seattle, WA Frank McKeon
Molecular Basis and Therapeutic Targeting of Bone Metastasis Co-Chairpersons: Yibin Kang, Princeton University, Princeton, NJ, and Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA Matthew Smith
Molecular and Cellular Determinants of Brain Metastasis Co-Chairpersons: William C. Hahn, Dana-Farber Cancer Institute, Boston, MA, and Joan Massagué, Memorial Sloan-Kettering Cancer Center, New York, NY Rakesh K Jain, William C Hahn
Avatar: Individualized Human Cancer Models in Mice Kwok-Kin Wong
Next-Generation Therapeutic Modeling in Mice Pier Paolo
The Utility of Cancer Cell Line Screens for Modeling Drug Sensitivities Moderator: Jeffrey Settleman, Genentech, Inc., South San Francisco, CA Levi A Garraway
Clinical Trials Based on Mutations versus Histology William R Sellers, Lewis C Cantley
Human Papillomavirus: Beyond Cervical Cancer Chairperson: Maura L. Gillison, The Ohio State University Comprehensive Cancer Center, Columbus, OH Peter M Howley
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Targeting Mechanisms of Therapeutic Resistance Chairperson: Matt V. Lorenzi, Janssen Research & Development, Spring House, PA Kwok-Kin Wong
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY Anthony G. Letai
Therapeutic Nanotechnology Chairperson: Gregory Lanza, Washington University, St. Louis, MO Omid C Farokhzad
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Scott A. Armstrong
The Next Frontier in Targeted Therapy for Melanoma Chairperson to be announced Lynda Chin
New Paradigms in Molecular Pharmacology Chairperson: Angela N. Koehler, Broad Institute of MIT and Harvard, Cambridge, MA James E. Bradner
Metabolism and Signaling in Cancer Chairperson: Eyal Gottlieb, The Beatson Institute for Cancer Research, Glasgow, United Kingdom Nika N. Danial
Immune Modulation in the Tumor Microenviroment Chairperson: James P. Allison, Memorial Sloan-Kettering Cancer Center, New York, NY Raghu Kalluri
Cancer Imaging in Mice and Men Andrew L. Kung, Dana-Farber Cancer Institute, Boston, MA Andrew Kung
2-Oxoglutarate-Dependent Dioxygenases as Targets of Cancer-Causing Mutations and Cancer Therapeutics William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, MA William G Kaelin
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY Xandra O Breakefield
Autocrine Activation of MET and Strategies to Overcome Adaptation for the Targeted Therapy of Acute Myeloid Leukemia A. Thomas Look, Dana-Farber Cancer Institute, Boston, MA Thomas A. Look
Stapled Peptides as Next-Generation Therapeutics Gregory L. Verdine, Harvard University, Cambridge, MA Gregory L Verdine
Prognostic and Predictive Biomarkers of Triple-Negative Breast Cancer Andrea L. Richardson, Brigham and Women's Hospital, Boston, MA Andrea L Richardson
Cancer Omics Beyond the Genome Sunney Xie
16th Annual Grant Writing Workshop Building Presence and Leadership through Empowered Communication Co-Chairpersons: Martine J. Piccart, Institut Jules Bordet, Brussels, Belgium, and Victoria M. Richon. Epizyme, Inc., Wellesley Hills, MA Kornelia Polyak
Patient-Derived Xenograft Models of Cancer: Where Are We Going? Chairperson: Matthew J. Ellis, Washington University Siteman Cancer Center, St. Louis, MO Tan Ince
WICR Career Mentoring Session Joan S Brugge
July 15, 2012 53rd Annual Short Course on Medical and Experimental Mammalian Genetics Evening Lecture | Title TBD David Altshuler
Title TBD Paul Ridker
Pecking at the Origin of Natural Variation: Insights from Darwin’s Finches and Other Birds Arkhat Abzhanov
March 25, 2012 ISA 2012 - XVI International Symposium on Atherosclerosis Healthy Drinking an Important Component of Healthy Eating Frank B. Hu
December 13, 2011 New Horizons in Cancer Research: Biology to Prevention to Therapy Welcome and Opening Remarks Judy Garber
Epigenetics of hormone dependence Myles Brown
December 4, 2011 Update in Internal Medicine Oncology: Challenging Cases with Your Participation Lowell E Schnipper
Oncology Q & A Lowell E Schnipper
Cancer: From Bench to Bedside Lowell E Schnipper
Introduction and Welcome Martin J Abrahamson
New Frontiers in Radiology Jonathan B. Kruskal
Endocrinology Q & A Martin J Abrahamson
Endocrinology: Challenging Cases with Your Participation Martin J Abrahamson
Treatment of Type 2 Diabetes 2011: Advances, Challenges and Opportunities Martin J Abrahamson
The Evaluation and Management of Common Disorders of the Knee C. Christopher Smith
Panel Discussion Martin J Abrahamson
Delivering Customer Service Excellence Martin J Abrahamson
Hypertension 2011: Recent Trials and Rational Therapy Gerald W. Smetana
September 30, 2011 Revisiting IBD Management: Dogmas to be Challenged Wrap-up Stuart Schreiber
Dogma 6 – Innovative treatments will offer a better outcome for patients with IBD Stuart Schreiber
Can we slow down evolution from early to late CD? Stuart Schreiber
March 1, 2011 "The Latest Advances in Liver Cancer Research: From Basic Science to Therapeutics" Session 3 | (title will be announced later) Sonia Friedman
Sessions 3 | (title will be announced later) Sonia Friedman
November 7, 2010 Ninth Annual International Conference on Frontiers in Cancer Prevention Research PARP inhibitors: Early promise in breast and ovarian cancer prevention Judy E Garber
Clinical trials in neurofibromatosis 1 and 2 Scott Plotkin
September 30, 2010 Third AACR Conference on The Science of Cancer Health Disparities From genomics to personalized medicine in oncology Levi A Garraway
Title to be announced Deborah Schrag
July 15, 2010 Osteoporosis 2010: New Insights in Research, Diagnosis, and Clinical Care Beyond BMD: Bone Quality and Bone Strength Mary L. Bouxsein
Special Topics in Osteoporosis Mary L. Bouxsein
June 6, 2010 The Future of Molecular Epidemiology: New Tools, Biomarkers, and Opportunities Welcome and Keynote Session: Where is Molecular Epidemiology? David J. Hunter
April 11, 2010 Molecular Targets for Control of Vector-Borne Diseases: Bridging Lab and Field Research (F2) * Multigene Families: Role in Immunity and Pathology | Big Horn B Peter R. Preiser
January 22, 2010 2010 Gastrointestinal Cancers Symposium General Session IV: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract: Prevention, Screening, and Diagnosis Sapna Syngal
Normalizing the Tumor Microenvironment to Improve Drug Delivery and Efficacy Rakesh K Jain
Newer Radiation Techniques in the Treatment of Hepatobiliary and Pancreatic Cancers Harvey J. Mamon
Advanced Imaging Techniques Dushyant Sahani
Gastroenterologist William R. Brugge
Advanced Imaging Techniques Dushyant Sahani
October 1, 2009 6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO) Case Presentation 1: Stage II David Ryan
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.